Scarica l'app Stockscreener
1.21
6.92%
-0.09
Dopo l'orario di chiusura:
1.17
-0.04
-3.31%
Precedente Chiudi:
$1.30
Aprire:
$1.33
Volume 24 ore:
33,248
Relative Volume:
0.60
Capitalizzazione di mercato:
$3.42M
Reddito:
-
Utile/perdita netta:
$-4.69M
Rapporto P/E:
-0.5193
EPS:
-2.33
Flusso di cassa netto:
$-3.81M
1 W Prestazione:
-8.33%
1M Prestazione:
-55.84%
6M Prestazione:
-33.88%
1 anno Prestazione:
-50.04%
Intervallo 1D:
$1.21
$1.33
Intervallo di 1 settimana:
$1.21
$1.55
Portata 52W:
$1.21
$4.40
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Nome
Lixte Biotechnology Holdings Inc
Settore
Industria
Telefono
310 203 2902
Indirizzo
248 ROUTE 25A, EAST SETAUKET
Confronta LIXT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
1.21 | 3.42M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 75.07B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.96B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.79B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 27.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie
LIXTE Adds Northwestern University’s Lurie Cancer Center as - GlobeNewswire
LIXTE Biotechnology Teams Up with Lurie Cancer Center to Initiate Clinical Trial of LB-100 and GSK’s Dostarlimab for Ovarian Clear Cell Cancer - Nasdaq
Can LIXTE's Cancer Drug Breakthrough Succeed Where Others Failed? Northwestern Joins Trial - StockTitan
Lixte Biotechnology faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
Lixte Biotechnology faces Nasdaq delisting over equity shortfall - Investing.com India
Lixte Biotechnology Holdings, Inc. Announces Successful Closure of $1.05 Million Offering - Defense World
Lixte Biotechnology announces closing of $1.05M registered direct offering - Yahoo Finance
LIXTE Biotechnology Announces Closing of $1.05 Million - GlobeNewswire
Lixte Biotechnology Closes $1.1 Million Direct Offering -February 13, 2025 at 11:06 am EST - Marketscreener.com
LIXTE Biotechnology Holdings, Inc. Completes Registered Direct Offering and Private Placement Raising Approximately $1.05 Million - Nasdaq
LIXTE Secures Critical $1.05M Funding: Strategic Move Unlocks Next Growth Phase - StockTitan
LIXTE Biotechnology announces $1.05M registered direct offering; shares fall - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
LIXTE Biotech (LIXT) Secures Fresh Capital: Strategic $1.05M Direct Offering Includes Warrant Sweetener - StockTitan
Lixte Biotechnology Holdings Inc Inc. (LIXT) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement - GlobeNewswire
LIXTE (LIXT) Halts Public Offering Plans: Strategic Shift or Financial Setback? - StockTitan
Lixte Biotechnology enters agreement for at-the-market stock sale - Investing.com
Lixte Biotechnology Holdings, Inc. Enters into At-the-Market Sales Agreement with WallachBeth Capital, LLC - Defense World
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) Short Interest Update - Defense World
Lixte Biotechnology Holdings, Inc. Vice President and COO Resigns - Defense World
Lixte Biotechnology announces executive departure By Investing.com - Investing.com Nigeria
Lixte Biotechnology announces executive departure - Investing.com
US Penny Stocks To Watch In December 2024 - Simply Wall St
LIXT (Lixte Biotechnology Holdings) 3-Year Sharpe Ratio : -0.39 (As of Dec. 05, 2024) - GuruFocus.com
LIXTE Biotechnology inks amendment to cancer drug study agreement - Investing.com
LIXTE Biotechnology inks amendment to cancer drug study agreement By Investing.com - Investing.com Nigeria
Lixte Biotechnology Holdings, Inc. Enters into Development Collaboration Agreement with the Netherlands Cancer Institute, Amsterdam - Marketscreener.com
Lixte Biotechnology Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
LIXTW (Lixte Biotechnology Holdings) Accounts Payable & Acc - GuruFocus.com
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
LIXT stock touches 52-week low at $1.53 amid market challenges - Investing.com Australia
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
LIXT stock touches 52-week low at $1.53 amid market challenges By Investing.com - Investing.com South Africa
Lixte Biotechnology granted extension to meet Nasdaq listing rules By Investing.com - Investing.com Australia
Lixte Biotechnology granted extension to meet Nasdaq listing rules - Investing.com
Lixte Biotechnology Holdings Inc WT (LIXTW-Q) QuotePress Release - The Globe and Mail
Omeros (OMER) Shares Drop 5.04% Amid Financial Struggles - GuruFocus.com
MRVI Stock Drops 5.11% Amid Financial Report Release - GuruFocus.com
Lixte Biotechnology (NASDAQ:LIXT) Stock Price Down 2.1% - Defense World
LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy - GlobeNewswire
Should investors be concerned about LYT’s high price-to-sales ratio? - US Post News
Lilium (NASDAQ:LILM) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Liquidia Co. (NASDAQ:LQDA) Shares Bought by Rhumbline Advisers - Defense World
Pacer Advisors Inc. Has $16.07 Million Stock Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World
Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex
Renaissance Technologies LLC Sells 2,000 Shares of LSI Industries Inc. (NASDAQ:LYTS) - Defense World
Texas Permanent School Fund Corp Trims Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World
First Eagle Investment Management LLC Increases Stake in LSI Industries Inc. (NASDAQ:LYTS) - Defense World
Lixte Biotechnology Holdings Inc Azioni (LIXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.45%
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):